| RS2551045296 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2551047604 |
TCF12
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 26 with or without anosmia, Hypogonadotropic hypogonadism 26 with or without anosmia |
| RS2551074619 |
HERC1
|
Health Risk |
Pathogenic |
Macrocephaly, dysmorphic facies |
| RS2551077319 |
HERC1
|
Health Risk |
Pathogenic |
— |
| RS2551081507 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS2551084284 |
TCF12
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS2551084305 |
TCF12
|
Health Risk |
Likely pathogenic |
TCF12-related craniosynostosis, TCF12-related craniosynostosis |
| RS2551103543 |
MAPKBP1
|
Health Risk |
Likely pathogenic |
Nephronophthisis 20, Nephronophthisis 20 |
| RS2551273132 |
HERC1
|
Health Risk |
Likely pathogenic |
Macrocephaly, dysmorphic facies |
| RS2551278986 |
TCF12
|
Health Risk |
Likely pathogenic |
Delayed speech and language development, Global developmental delay |
| RS2551285409 |
HERC1
|
Health Risk |
Pathogenic |
Macrocephaly, dysmorphic facies |
| RS2551314154 |
TCF12
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2551324651 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2551345158 |
HERC1
|
Health Risk |
Pathogenic |
— |
| RS2551395033 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2551418406 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2551438273 |
TCF12
|
Health Risk |
Likely pathogenic |
TCF12-related craniosynostosis, TCF12-related craniosynostosis |
| RS2551438479 |
TCF12
|
Health Risk |
Pathogenic |
— |
| RS2551443212 |
TCF12
|
Health Risk |
Likely pathogenic |
— |
| RS2551443653 |
TCF12
|
Health Risk |
Likely pathogenic |
TCF12-related craniosynostosis, TCF12-related craniosynostosis |
| RS2551453077 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2551464938 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2551469564 |
TCF12
|
Health Risk |
Conflicting classifications of pathogenicity |
TCF12-related craniosynostosis, TCF12-related craniosynostosis |
| RS2551469629 |
TCF12
|
Health Risk |
Pathogenic |
TCF12-related craniosynostosis, TCF12-related craniosynostosis |
| RS2551469699 |
TCF12
|
Health Risk |
Pathogenic |
TCF12-related disorder, TCF12-related disorder |
| RS2551470484 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2551473219 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2551482755 |
TCF12
|
Health Risk |
Pathogenic |
— |
| RS2551484806 |
TCF12
|
Health Risk |
Pathogenic |
— |
| RS2551484936 |
TCF12
|
Health Risk |
Pathogenic |
— |
| RS2551484992 |
TCF12
|
Health Risk |
Likely pathogenic |
TCF12-related disorder, TCF12-related disorder |
| RS2551485019 |
TCF12
|
Health Risk |
Pathogenic |
— |
| RS2551485477 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2551487239 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2551490627 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2551491616 |
TCF12
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2551491638 |
TCF12
|
Health Risk |
Pathogenic |
— |
| RS2551491721 |
TCF12
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2551492564 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2551492625 |
TCF12
|
Health Risk |
Pathogenic |
— |
| RS2551492629 |
TCF12
|
Health Risk |
Pathogenic |
— |
| RS2551492642 |
TCF12
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS2551492702 |
TCF12
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 26 with or without anosmia, Hypogonadotropic hypogonadism 26 with or without anosmia |
| RS2551492921 |
TCF12
|
Health Risk |
Likely pathogenic |
TCF12-related disorder, TCF12-related disorder |
| RS2551493276 |
HERC1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2551495416 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2551496109 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS2551499549 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2551499709 |
TOPORS
|
Health Risk |
Likely pathogenic |
— |
| RS2551500621 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2551501177 |
TCF12
|
Health Risk |
Pathogenic |
— |
| RS2551501239 |
TCF12
|
Health Risk |
Pathogenic |
— |
| RS2551501285 |
TCF12
|
Health Risk |
Pathogenic |
— |
| RS2551501289 |
TCF12
|
Health Risk |
Likely pathogenic |
— |
| RS2551501300 |
TCF12
|
Health Risk |
Pathogenic |
TCF12-related craniosynostosis, TCF12-related craniosynostosis |
| RS2551501386 |
TCF12
|
Health Risk |
Pathogenic |
— |
| RS2551501427 |
TCF12
|
Health Risk |
Pathogenic |
— |
| RS2551505115 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2551505402 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2551545295 |
SYNE1
|
Health Risk |
Likely pathogenic |
SYNE1-related disorder, SYNE1-related disorder |
| RS2551593769 |
KCNMA1
|
Health Risk |
Pathogenic |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS2551617809 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2551620475 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2551625320 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2551628076 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2551643451 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |
| RS2551647323 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |
| RS2551647849 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2551663650 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2551667327 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Nemaline myopathy 2 |
| RS2551667649 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |
| RS2551669530 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2551671374 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |
| RS2551671576 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2551671834 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2551672017 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |
| RS2551679304 |
BRCA1
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2551689269 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2551692654 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2551693911 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2551694835 |
SYNE1
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS2551694878 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2551697220 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2551698321 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2551700360 |
MYZAP
|
Health Risk |
Pathogenic |
Cardiomyopathy, dilated |
| RS2551706794 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2551706848 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2551707143 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2551707232 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2551707826 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2551708075 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |
| RS2551710477 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2551714172 |
KCNMA1
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2551725763 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2551726011 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |
| RS2551726176 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2551726251 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2551726369 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2551726479 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2551726621 |
NEB
|
Health Risk |
Pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |